Treatment of hyperacute antibody-mediated lung allograft rejection with eculizumab

被引：49
|
作者：
Dawson, Kyle L. [1 ]
Parulekar, Amit [2 ]
Seethamraju, Harish [3 ]
机构：
[1] Methodist Hosp, Dept Pharm, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pulm & Crit Care Med, Houston, TX 77030 USA
[3] Methodist Hosp, Dept Med, Houston, TX 77030 USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2012年 / 31卷 / 12期
关键词：
TRANSPLANTATION;
D O I：
10.1016/j.healun.2012.09.016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1325 / 1326
页数：2
相关论文
共 50 条
  • [41] Macrophage activation in antibody-mediated renal allograft rejection
    Agrawal, V.
    Kamthan, S.
    Singh, S. Pratap
    Prasad, N.
    VIRCHOWS ARCHIV, 2024, 485 : S38 - S38
  • [42] Renal Allograft Macrophage Infiltration in Antibody-Mediated Renal Allograft Rejection
    Agrawal, V
    Kamthan, S.
    Singh, S. Pratap
    Prasad, N.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 162 : S142 - S142
  • [43] Rituximab and Intravenous Immunoglobulin Treatment of Chronic Antibody-Mediated Kidney Allograft Rejection
    Fehr, Thomas
    Ruesi, Barbara
    Fischer, Andreas
    Hopfer, Helmut
    Wuethrich, Rudolf P.
    Gaspert, Ariana
    TRANSPLANTATION, 2009, 87 (12) : 1837 - 1841
  • [44] Rituximab and intravenous immunoglobulin treatment for chronic antibody-mediated renal allograft rejection
    Fehr, T.
    Gaspert, A.
    Ruesi-Elsener, B.
    Weber, M.
    Fischer, A.
    Wuethrich, R. P.
    SWISS MEDICAL WEEKLY, 2008, 138 (47-48) : 15S - 15S
  • [45] Complement Inhibition for Prevention and Treatment of Antibody-Mediated Rejection in Renal Allograft Recipients
    Jordan, S. C.
    Choi, J.
    Kahwaji, J.
    Vo, A.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (03) : 806 - 808
  • [46] Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection
    Waiser, Johannes
    Budde, Klemens
    Schuetz, Manuela
    Liefeldt, Lutz
    Rudolph, Birgit
    Schoenemann, Constanze
    Neumayer, Hans-H
    Lachmann, Nils
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (03) : 1246 - 1251
  • [47] New concepts in chronic antibody-mediated kidney allograft rejection: prevention and treatment
    Mayer, Katharina A.
    Doberer, Konstantin
    Eskandary, Farsad
    Halloran, Philip F.
    Bohmig, Georg A.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2021, 26 (01) : 97 - 105
  • [48] TARGETING CD38 AS A NEW TREATMENT OF ANTIBODY-MEDIATED ALLOGRAFT REJECTION
    Doberer, K.
    Klaeger, J.
    Gualdoni, G.
    Reindl-Schwaighofer, R.
    Cohen, G.
    Reiter, T.
    Eskandary, F.
    Wahrmann, M.
    Bond, G.
    Simonitsch-Klupp, I.
    Regele, H.
    Agis, H.
    Halloran, P. F.
    Boehmig, G. A.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 15 - 15
  • [49] Hyperacute Antibody-mediated Rejection Associated With Red Blood Cell Antibodies
    Shaw, James
    Gibson, Ian W.
    Wiebe, Chris
    Houston, Donald S.
    Koulack, Joshua
    Rush, David
    Nickerson, Peter
    Ho, Julie
    TRANSPLANTATION DIRECT, 2019, 5 (08):
  • [50] Treatment of Acute Antibody-Mediated Rejection
    Comai, Giorgia
    Ravaioli, Matteo
    Baraldi, Olga
    Cuna, Vania
    Gasperoni, Lorenzo
    D'Arcangelo, Giovanni Liviano
    Cappuccilli, Maria
    Pinna, Antonio D.
    Ronco, Claudio
    La Manna, Gaetano
    CURRENT PERSPECTIVES IN KIDNEY DISEASES, 2017, 190 : 156 - 167
12345